Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

SF3B1 mutations K700E, K666N, and R625H: Gene expression and aberrant splicing consequences

View Full Paper
Ask AI
Bookmark
Share

Authors

JHJohn HarperEHElodie HenrietOAOmar Abdel‐Wahab

Discussion

Loading...

Member takes

Overview

Observational analysis reveals altered gene expression and splicing in MDS linked to SF3B1 mutations, highlighting potential therapeutic strategies.

Key Points

  • Aberrant splicing linked to SF3B1 mutations affects hematopoiesis and immune responses.
  • Differential gene expression analysis exhibited unique patterns corresponding to specific SF3B1 mutations.
  • Study utilized RNA sequencing and alternative splicing methods to elucidate molecular mechanisms in MDS.
  • Findings suggest that mutation-specific splicing alterations may inform future therapies for acute myeloid leukemia.

Cite This Study

Harper et al. (2025) studied this question.

synapsesocial.com/papers/69362f574fa91c937236da34https://doi.org/10.1182/blood-2025-5618
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impact of different Sf3b1 mutations on hematopoietic function and erythropoiesis2025
  2. 2Variant-specific SF3B1 mutations drive distinct splicing and mitochondrial dysfunction in myelodysplastic neoplasms2026
  3. 3CDK8 is a critical effector of cell fate dysregulation in SF3B1 -mutant MDS2025
  4. 4Transcriptional and splicing dysregulation by U2AF1 mutations contribute to inflammatory and migratory alterations in MDS2025
  5. 5Sf3b1+/K700E hematopoietic stem cells create their own expansion niche2025